Treatment
Tirzepatide Weight Loss
Clinically proven medical weight loss
Overview
Tirzepatide is a groundbreaking GLP-1/GIP dual receptor agonist that has revolutionized medical weight loss. FDA-approved and clinically proven, it works by mimicking two natural gut hormones that regulate appetite, blood sugar, and metabolism — helping patients achieve significant, sustainable weight loss without surgery.
How It Works
Tirzepatide is administered as a once-weekly subcutaneous injection. It activates both GLP-1 and GIP receptors in the brain and gut, reducing hunger signals, slowing gastric emptying, and improving insulin sensitivity. Clinical trials showed an average weight loss of 15–22% of body weight over 72 weeks.
What to Expect
Your journey begins with a comprehensive consultation to assess your health history, goals, and candidacy. We start at a low dose and gradually titrate upward over several weeks to minimize side effects. Most patients notice reduced appetite within the first week. Monthly follow-ups track progress and adjust your plan.
Recovery
No downtime. Mild injection-site reactions or nausea may occur in the first few weeks as your body adjusts. These typically resolve as the dose is titrated.
See the Procedure
How Tirzepatide works for medical weight loss
How Tirzepatide works for medical weight loss
Before & After
Real patient results. Individual results may vary.
Tirzepatide Weight Loss — Patient 1
Individual results may vary.
Tirzepatide Weight Loss — Patient 2
Individual results may vary.
Tirzepatide Weight Loss — Patient 3
Individual results may vary.
Frequently Asked Questions
Explore Other Treatments
Ready to experience Tirzepatide Weight Loss?
Schedule a personalized consultation with our board-certified team in Westminster, CA.
Share this treatment